Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thalidomide for patients with recurrent lymphoma.
Pro B, Younes A, Albitar M, Dang NH, Samaniego F, Romaguera J, McLaughlin P, Hagemeister FB, Rodriguez MA, Clemons M, Cabanillas F. Pro B, et al. Among authors: romaguera j. Cancer. 2004 Mar 15;100(6):1186-9. doi: 10.1002/cncr.20070. Cancer. 2004. PMID: 15022285 Free article.
A pilot study of rituximab in patients with recurrent, classic Hodgkin disease.
Younes A, Romaguera J, Hagemeister F, McLaughlin P, Rodriguez MA, Fiumara P, Goy A, Jeha S, Manning JT Jr, Jones D, Abruzzo LV, Medeiros LJ. Younes A, et al. Among authors: romaguera j. Cancer. 2003 Jul 15;98(2):310-4. doi: 10.1002/cncr.11511. Cancer. 2003. PMID: 12872350 Free article. Clinical Trial.
Lymphoma of the colon.
Romaguera J, Hagemeister FB. Romaguera J, et al. Curr Opin Gastroenterol. 2005 Jan;21(1):80-4. Curr Opin Gastroenterol. 2005. PMID: 15687889 Review.
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma.
Pro B, Fayad L, McLaughlin P, Romaguera J, Hagemeister FB, Rodriguez MA, Goy A, Loyer E, Younes A. Pro B, et al. Among authors: romaguera j. Leuk Lymphoma. 2006 Mar;47(3):481-5. doi: 10.1080/10428190500305802. Leuk Lymphoma. 2006. PMID: 16396772 Clinical Trial.
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma.
Pro B, Leber B, Smith M, Fayad L, Romaguera J, Hagemeister F, Rodriguez A, McLaughlin P, Samaniego F, Zwiebel J, Lopez A, Kwak L, Younes A. Pro B, et al. Among authors: romaguera j. Br J Haematol. 2008 Nov;143(3):355-60. doi: 10.1111/j.1365-2141.2008.07353.x. Epub 2008 Sep 1. Br J Haematol. 2008. PMID: 18764869 Free article. Clinical Trial.
311 results